| 4701 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
34 |
| 4702 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
42 |
| 4703 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
62 |
| 4704 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
56 |
| 4705 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
67 |
| 4706 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
68 |
| 4707 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4708 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4709 |
Apheresis |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2020 |
Standard Therapy |
Poland |
57 |
| 4710 |
Apheresis |
Allogeneic |
Perforin Deficiency |
Hematology |
2020 |
Standard Therapy |
Poland |
2 |
| 4711 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
59 |
| 4712 |
Apheresis |
Autologous |
Primary Cerebral Diffuse Large B-Cell Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
66 |
| 4713 |
Apheresis |
Autologous |
Primary Cerebral Diffuse Large B-Cell Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
59 |
| 4714 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4715 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
61 |
| 4716 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
51 |
| 4717 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
66 |
| 4718 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
61 |
| 4719 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Germany |
54 |
| 4720 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Germany |
58 |
| 4721 |
Apheresis |
Allogeneic |
Purine Nucleoside Phosphorylase Deficiency |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4722 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
43 |
| 4723 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
76 |
| 4724 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
57 |
| 4725 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Germany |
66 |
| 4726 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Germany |
56 |
| 4727 |
Apheresis |
Autologous |
Secondary B-Cell Non-Hodgkin-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
73 |
| 4728 |
Apheresis |
Autologous |
Secondary Diffuse Large B-Cell Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
54 |
| 4729 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
9 |
| 4730 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
53 |
| 4731 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4732 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2020 |
Standard Therapy |
Poland |
2 |
| 4733 |
Apheresis |
Allogeneic |
Sezary Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
44 |
| 4734 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
14 |
| 4735 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
57 |
| 4736 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
29 |
| 4737 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
64 |
| 4738 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
63 |
| 4739 |
Apheresis |
Allogeneic |
T-Cell-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
29 |
| 4740 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
51 |
| 4741 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
60 |
| 4742 |
Apheresis |
Allogeneic |
T-Cell-Prolymphocytic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
55 |
| 4743 |
Apheresis |
Allogeneic |
T-Cell-Prolymphocytic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
74 |
| 4744 |
Apheresis |
Allogeneic |
Β – Thalassemia |
Hematology |
2020 |
Standard Therapy |
Poland |
6 |
| 4745 |
Apheresis |
Allogeneic |
Β – Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Poland |
17 |
| 4746 |
Adipose Tissue |
Autologous |
Alopecia |
Dermatology |
2020 |
Experimental Therapy |
Poland |
68,5 |
| 4747 |
Adipose Tissue |
Autologous |
Chondromalacia |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
45,9 |
| 4748 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
52,8 |
| 4749 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
63,4 |
| 4750 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
41,1 |
| 4751 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
34,8 |
| 4752 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
48,1 |
| 4753 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
57,11 |
| 4754 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
59,8 |
| 4755 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
35,1 |
| 4756 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
61,8 |
| 4757 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
56,5 |
| 4758 |
Adipose Tissue |
Autologous |
Gonarthrosis; Shoulder Osteoarthritis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
42,5 |
| 4759 |
Adipose Tissue |
Autologous |
Internal Damage To The Knee Joint |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
53,6 |
| 4760 |
Adipose Tissue |
Autologous |
Internal Damage To The Knee Joint |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
49,2 |
| 4761 |
Adipose Tissue |
Autologous |
Omarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
70,1 |
| 4762 |
Adipose Tissue |
Autologous |
Other Acquired Deformities Of The Ankle And Foot |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
41,6 |
| 4763 |
Adipose Tissue |
Autologous |
Scar |
Dermatology |
2020 |
Clinical Trial |
Poland |
no data |
| 4764 |
Adipose Tissue |
Autologous |
Soft Tissue Diseases Related To Use, Overload And Pressure |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
61,1 |
| 4765 |
Cord Tissue |
Allogeneic – Unrelated |
Limb-Girdle Muscular Dystrophy |
Neurology |
2019 |
Experimental Therapy |
Poland |
5,3 |
| 4766 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2019 |
Experimental Therapy |
Poland |
1,9 |
| 4767 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2019 |
Experimental Therapy |
Poland |
6,1 |
| 4768 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2019 |
Experimental Therapy |
Poland |
2,2 |
| 4769 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2019 |
Experimental Therapy |
Poland |
10,1 |
| 4770 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2019 |
Experimental Therapy |
Poland |
18,2 |
| 4771 |
Cord Tissue |
Allogeneic – Unrelated |
Acute Graft Versus Host Disease |
Hematology |
2019 |
Experimental Therapy |
Poland |
10,2 |
| 4772 |
Cord Tissue |
Allogeneic – Unrelated |
Agenesis Of Corpus Callosum; Atrophy Of The Optic Nerves |
Neurology |
2019 |
Experimental Therapy |
Poland |
7,3 |
| 4773 |
Cord Tissue |
Allogeneic – Unrelated |
Alopecia Areata |
Dermatology |
2019 |
Experimental Therapy |
Poland |
47,11 |
| 4774 |
Cord Tissue |
Allogeneic – Unrelated |
Alopecia Areata |
Dermatology |
2019 |
Experimental Therapy |
Poland |
57,9 |
| 4775 |
Cord Tissue |
Allogeneic – Unrelated |
Alopecia Areata |
Dermatology |
2019 |
Experimental Therapy |
Poland |
43,3 |
| 4776 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
54,9 |
| 4777 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
58,7 |
| 4778 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
65,5 |
| 4779 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
60,11 |
| 4780 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
38,2 |
| 4781 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
61,9 |
| 4782 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
70,11 |
| 4783 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
73,1 |
| 4784 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
58,1 |
| 4785 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
65,1 |
| 4786 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
39,8 |
| 4787 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
46,1 |
| 4788 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
59,1 |
| 4789 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
61 |
| 4790 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
66,2 |
| 4791 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
44,1 |
| 4792 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
65,1 |
| 4793 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
65 |
| 4794 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
41,5 |
| 4795 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
59,8 |
| 4796 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
32,2 |
| 4797 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
56,1 |
| 4798 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
61,5 |
| 4799 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
49,7 |
| 4800 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic Lateral Sclerosis |
Neurology |
2019 |
Experimental Therapy |
Poland |
67,11 |